{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:18:26Z","timestamp":1790936306332,"version":"4.1.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20 K09360"],"award-info":[{"award-number":["20 K09360"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shiga Medical Center Research Institute"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Anti-vascular endothelial growth factor (VEGF) therapy has been developed for the treatment of a variety of cancers. Although this therapy may be a promising alternative treatment for refractory pituitary adenomas and pituitary carcinomas, the effects of anti-VEGF agents on the pituitary gland are not yet well understood. Here, we found that mice administered with OSI-930, an inhibitor of receptor tyrosine kinases including VEGF receptor 1 and 2, frequently exhibited hemorrhage in the pituitary gland. This is the first report that anti-VEGF therapy can cause pituitary apoplexy. C57BL\/6 mice were daily injected intraperitoneally with 100 mg\/kg body weight of OSI-930 for one to six days. Pituitary glands were immunohistochemically examined. Four of six mice treated for three days and all of five mice treated for six days exhibited hemorrhage in the pituitary gland. In all cases, the hemorrhage occurred just around Rathke\u2019s cleft. In OSI-930-administered mice, the vascular coverage and branching were reduced in the anterior lobe, and capillary networks were also decreased in the intermediate lobe in a treatment-day dependent manner. Few blood vessels around Rathke\u2019s cleft of the intermediate lobe express VE-cadherin and are covered with platelet-derived growth factor receptor-\u03b2 (PDGFR-\u03b2)-positive cells, which suggests that capillaries around Rathke\u2019s cleft of the intermediate lobe were VE-cadherin-negative and not covered with pericytes. The reduction of capillary plexus around Rathke\u2019s cleft was observed at the site where hemorrhage occurred, suggesting a causal relationship with the pathogenesis of pituitary hemorrhage. Our study demonstrates that anti-VEGF agents have a risk of pituitary apoplexy. Pituitary apoplexy should be kept in mind as an adverse effect of anti-VEGF therapy.<\/jats:p>","DOI":"10.1371\/journal.pone.0279634","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T17:43:38Z","timestamp":1678988618000},"page":"e0279634","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inhibition of VEGF receptors induces pituitary apoplexy: An experimental study in mice"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3635-8656","authenticated-orcid":true,"given":"Yoshito","family":"Sugita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-888X","authenticated-orcid":true,"given":"Shigeki","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tanigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Muraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7517-2622","authenticated-orcid":true,"given":"Masato","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"issue":"4","key":"pone.0279634.ref001","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000488087","article-title":"Anti-Angiogenics: Current Situation and Future Perspectives","volume":"41","author":"K Zirlik","year":"2018","journal-title":"Oncol Res Treat"},{"issue":"4","key":"pone.0279634.ref002","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3171\/2015.4.JNS142200","article-title":"Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival","volume":"124","author":"R Babu","year":"2016","journal-title":"J Neurosurg"},{"issue":"12","key":"pone.0279634.ref003","doi-asserted-by":"crossref","first-page":"e048975","DOI":"10.1136\/bmjopen-2021-048975","article-title":"Efficacy and safety of bevacizumab in the treatment of adult gliomas: a systematic review and meta-analysis","volume":"11","author":"H Wang","year":"2021","journal-title":"BMJ Open"},{"issue":"34","key":"pone.0279634.ref004","doi-asserted-by":"crossref","first-page":"e4232","DOI":"10.1097\/MD.0000000000004232","article-title":"Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials","volume":"95","author":"X Zhu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"pone.0279634.ref005","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"T Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"pone.0279634.ref006","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0049-3848(12)70016-6","article-title":"Side effects of anti-angiogenic drugs","volume":"1","author":"F Elice","year":"2012","journal-title":"Thromb Res"},{"issue":"2","key":"pone.0279634.ref007","doi-asserted-by":"crossref","first-page":"H560","DOI":"10.1152\/ajpheart.00133.2005","article-title":"VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature","volume":"290","author":"T Kamba","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"pone.0279634.ref008","doi-asserted-by":"crossref","first-page":"773905","DOI":"10.3389\/fonc.2021.773905","article-title":"Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review","volume":"11","author":"C Dai","year":"2021","journal-title":"Front Oncol"},{"key":"pone.0279634.ref009","first-page":"1","article-title":"Radiological and clinical outcomes of pituitary apoplexy: comparison of conservative management versus early surgical intervention","author":"MJ Shepard","year":"2021","journal-title":"J Neurosurg"},{"key":"pone.0279634.ref010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/2152-7806.109654","article-title":"Chronic expanding pituitary hematoma without rebleeding after pituitary apoplexy","volume":"4","author":"M Hojo","year":"2013","journal-title":"Surg Neurol Int"},{"issue":"2","key":"pone.0279634.ref011","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1055\/s-0035-1554909","article-title":"Pituitary Apoplexy After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitor: A Novel Complication","volume":"76","author":"RA Kasl","year":"2015","journal-title":"J Neurol Surg Rep"},{"issue":"2","key":"pone.0279634.ref012","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/0008-5472.CAN-05-2873","article-title":"OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models","volume":"66","author":"AJ Garton","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"pone.0279634.ref013","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejca.2012.09.036","article-title":"A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours","volume":"49","author":"IR Macpherson","year":"2013","journal-title":"Eur J Cancer"},{"issue":"4","key":"pone.0279634.ref014","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/1078-0432.CCR-12-2258","article-title":"First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies","volume":"19","author":"TA Yap","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"7","key":"pone.0279634.ref015","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"N Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"issue":"3","key":"pone.0279634.ref016","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neures.2013.01.006","article-title":"Notch signaling regulates nucleocytoplasmic Olig2 translocation in reactive astrocytes differentiation after ischemic stroke","volume":"75","author":"T Marumo","year":"2013","journal-title":"Neurosci Res"},{"issue":"5","key":"pone.0279634.ref017","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.neuron.2014.07.034","article-title":"Sensory-related neural activity regulates the structure of vascular networks in the cerebral cortex","volume":"83","author":"B Lacoste","year":"2014","journal-title":"Neuron"},{"issue":"3","key":"pone.0279634.ref018","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2019EZR\u2019 for medical statistics","volume":"48","author":"Y. Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"pone.0279634.ref019","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/002215540205000410","article-title":"Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary","volume":"50","author":"S Vidal","year":"2002","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"pone.0279634.ref020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/joe.1.06992","article-title":"Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours","volume":"191","author":"C Onofri","year":"2006","journal-title":"J Endocrinol"},{"issue":"1","key":"pone.0279634.ref021","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/JOE-14-0075","article-title":"VEGF-dependent and PDGF-dependent dynamic neurovascular reconstruction in the neurohypophysis of adult mice","volume":"222","author":"E Furube","year":"2014","journal-title":"J Endocrinol"},{"issue":"10","key":"pone.0279634.ref022","doi-asserted-by":"crossref","first-page":"e0163981","DOI":"10.1371\/journal.pone.0163981","article-title":"S100beta-Positive Cells of Mesenchymal Origin Reside in the Anterior Lobe of the Embryonic Pituitary Gland","volume":"11","author":"K Horiguchi","year":"2016","journal-title":"PLoS One"},{"issue":"5323","key":"pone.0279634.ref023","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","article-title":"Pericyte loss and microaneurysm formation in PDGF-B-deficient mice","volume":"277","author":"P Lindahl","year":"1997","journal-title":"Science"},{"issue":"16","key":"pone.0279634.ref024","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1101\/gad.8.16.1888","article-title":"Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice","volume":"8","author":"P. Soriano","year":"1994","journal-title":"Genes Dev"},{"issue":"Pt 13","key":"pone.0279634.ref025","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1242\/jcs.017897","article-title":"The role of adherens junctions and VE-cadherin in the control of vascular permeability","volume":"121","author":"E Dejana","year":"2008","journal-title":"J Cell Sci"},{"issue":"9","key":"pone.0279634.ref026","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2174\/1570159X16666180222164809","article-title":"The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions","volume":"16","author":"W Li","year":"2018","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"pone.0279634.ref027","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2739\/kurumemedj.36.91","article-title":"Ultrastructure of the hypophyseal portal vessel in mature rats\u2014SEM and TEM observations","volume":"36","author":"H Satoh","year":"1989","journal-title":"Kurume Med J"},{"issue":"3","key":"pone.0279634.ref028","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000125722","article-title":"Analysis of the appearance of fenestrations in the blood vessels of the fetal sheep pituitary","volume":"53","author":"M Levidiotis","year":"1991","journal-title":"Neuroendocrinology"},{"issue":"1","key":"pone.0279634.ref029","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9440(10)63273-7","article-title":"Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts","volume":"165","author":"T Inai","year":"2004","journal-title":"The American Journal of Pathology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0279634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T17:44:14Z","timestamp":1678988654000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0279634"}},"subtitle":[],"editor":[{"given":"Takahiro","family":"Nemoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0279634","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}